Advertisement

COVID-19 Vaccine and Myocarditis

      The introduction of the various coronavirus disease-2019 (COVID-19) vaccines has resulted in a significant decline in COVID-19 related morbidity and mortality worldwide, and all the approved COVID-19 vaccines have proven to provide benefits that outweigh the potential risks among different age groups.
      • Haas EJ
      • Angulo FJ
      • McLaughlin JM
      • Anis E
      • Singer SR
      • Khan F
      • Brooks N
      • Smaja M
      • Mircus G
      • Pan K
      • Southern J
      • Swerdlow DL
      • Jodar L
      • Levy Y
      • Alroy-Preis S
      Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
      • Lv G
      • Yuan J
      • Xiong X
      • Li M.
      Mortality rate and characteristics of deaths following COVID-19 vaccination.
      • Lopez Bernal J
      • Andrews N
      • Gower C
      • Robertson C
      • Stowe J
      • Tessier E
      • Simmons R
      • Cottrell S
      • Roberts R
      • O'Doherty M
      • Brown K
      • Cameron C
      • Stockton D
      • McMenamin J
      • Ramsay M
      Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
      Recent reports have raised concerns for myocarditis related to different types of COVID-19 vaccines. However, there are limited data on the characteristics and outcomes of myocarditis in these patients. In this report, we aim to pool the available data to better understand the characteristics and outcomes of the COVID-19 vaccine-related myocarditis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Haas EJ
        • Angulo FJ
        • McLaughlin JM
        • Anis E
        • Singer SR
        • Khan F
        • Brooks N
        • Smaja M
        • Mircus G
        • Pan K
        • Southern J
        • Swerdlow DL
        • Jodar L
        • Levy Y
        • Alroy-Preis S
        Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
        Lancet. 2021; 397: 1819-1829
        • Lv G
        • Yuan J
        • Xiong X
        • Li M.
        Mortality rate and characteristics of deaths following COVID-19 vaccination.
        Front Med (Lausanne). 2021; 8670370
        • Lopez Bernal J
        • Andrews N
        • Gower C
        • Robertson C
        • Stowe J
        • Tessier E
        • Simmons R
        • Cottrell S
        • Roberts R
        • O'Doherty M
        • Brown K
        • Cameron C
        • Stockton D
        • McMenamin J
        • Ramsay M
        Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
        BMJ. 2021; 373: n1088
        • Mansour J
        • Short RG
        • Bhalla S
        • Woodard PK
        • Verma A
        • Robinson X
        • Raptis DA
        Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases.
        Clin Imaging. 2021; 78: 247-249
        • Minocha PK
        • Better D
        • Singh RK
        • Hoque T.
        Recurrence of acute myocarditis temporally associated with receipt of the mRNA COVID-19 vaccine in an adolescent male.
        J Pediatr. 2021; ([Epub ahead of print])
        • Rosner CM
        • Genovese L
        • Tehrani BN
        • Atkins M
        • Bakhshi H
        • Chaudhri S
        • Damluji AA
        • Lemos JAd
        • Desai SS
        • Emaminia A
        • Flanagan MC
        • Khera A
        • Maghsoudi A
        • Mekonnen G
        • Muthukumar A
        • Saeed IM
        • Sherwood MW
        • Sinha SS
        • O'Connor CM
        • deFilippi CR
        Myocarditis temporally associated with COVID-19 vaccination.
        Circulation. 2021; ([Epub ahead of print])
        • Muthukumar A
        • Narasimhan M
        • Li Q-Z
        • Mahimainathan L
        • Hitto I
        • Fuda F
        • Batra K
        • Jiang X
        • Zhu C
        • Schoggins J
        • Cutrell JB
        • Croft CL
        • Khera A
        • Drazner MH
        • Grodin JL
        • Greenberg BM
        • Mammen PPA
        • Morrison SJ
        • Lemos JAd
        In depth evaluation of a case of presumed myocarditis following the second dose of COVID-19 mRNA vaccine.
        Circulation. 2021; ([Epub ahead of print])
        • McLean K
        • Johnson TJ.
        Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: a case report.
        Acad Emerg Med. 2021; ([Epub ahead of print])
        • D'Angelo T
        • Cattafi A
        • Carerj ML
        • Booz C
        • Ascenti G
        • Cicero G
        • Blandino A
        • Mazziotti S.
        Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?.
        Can J Cardiol. 2021;
        • Albert E
        • Aurigemma G
        • Saucedo J
        • Gerson DS.
        Myocarditis following COVID-19 vaccination.
        Radiol Case Rep. 2021; 16: 2142-2145
        • Bautista García J
        • Peña Ortega P
        • Bonilla Fernández JA
        • Cárdenes León A
        • Ramírez Burgos L
        • Caballero Dorta E
        Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19.
        Rev Esp Cardiol (Engl Ed). 2021; ([Epub ahead of print])